V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003358 | 300002340 | 1.62 | 136.5 | null | 2017-10-30 | 2017-11-16 | Capecitabine | null | N | 300015370 | CAPECITABINE |
| 300003359 | 300002341 | 1.83 | 73.5 | Neo-adjuvant (N) | 2016-12-18 | 2017-01-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015382 | CISPLATIN + FLUOROURACIL |
| 300003360 | 300002342 | 1.75 | 88.5 | Adjuvant (A) | 2014-02-06 | 2014-02-06 | Capecitabine | N | N | 300015391 | CAPECITABINE |
| 300003361 | 300002342 | 1.8 | 68 | Palliative (P) | 2017-06-23 | 2017-06-23 | Capecitabine | 2 | N | 300015391 | CAPECITABINE |
| 300003364 | 300002344 | 1.7 | 63.8 | Curative (C) | 2015-12-07 | 2015-12-10 | Cetuximab + Radiotherapy Load | N | N | 300015399 | CETUXIMAB + RT |
| 300003365 | 300002345 | 1.75 | 42 | Neo-adjuvant (N) | 2017-10-28 | 2017-10-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300015408 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003366 | 300002346 | 1.8 | 42 | Neo-adjuvant (N) | 2017-07-27 | 2017-07-28 | CISPLATIN + FLUOROURACIL | N | N | 300015410 | CISPLATIN + FLUOROURACIL |
| 300003367 | 300002347 | 1.63 | 83 | Palliative (P) | 2014-08-21 | 2014-09-04 | Capecitabine | N | N | 300015412 | CAPECITABINE |
| 300003370 | 300002349 | null | 89.75 | Curative (C) | 2015-01-16 | 2015-02-01 | Trial Unspecified | Y | N | 300015416 | TRIAL |
| 300003371 | 300002350 | 1.68 | 87 | Curative (C) | 2016-11-22 | 2016-11-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015419 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003372 | 300002351 | null | 61.8 | Palliative (P) | 2014-01-03 | 2014-02-11 | Cisplatin +Fluorouracil (2 wk) | Y | N | 300015420 | CISPLATIN + FLUOROURACIL |
| 300003374 | 300002353 | null | null | Palliative (P) | 2014-08-07 | 2014-08-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300015430 | CARBOPLATIN + PACLITAXEL |
| 300003375 | 300002353 | 1.75 | null | Neo-adjuvant (N) | 2013-10-03 | 2014-01-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015430 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003377 | 300002355 | 1.63 | 65.7 | Curative (C) | 2017-10-13 | 2017-10-13 | Cetuximab + Radiotherapy Load | 02 | Y | 300015450 | CETUXIMAB + RT |
| 300003378 | 300002356 | 1.59 | 95 | Palliative (P) | 2016-10-07 | 2016-10-09 | Trial Unspecified | N | N | 300015452 | TRIAL |
| 300003379 | 300002357 | null | null | Curative (C) | 2016-06-26 | 2016-06-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015453 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003381 | 300002359 | 1.45 | 85 | Curative (C) | 2015-08-27 | 2015-09-19 | Trial Unspecified | N | Y | 300015457 | TRIAL |
| 300003382 | 300002360 | 1.69 | 42 | 3 | 2016-11-01 | 2016-11-07 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015460 | CISPLATIN + FLUOROURACIL |
| 300003383 | 300002360 | null | 65.4 | 2 | 2016-07-17 | 2016-08-10 | CISPLATIN + FLUOROURACIL | 02 | N | 300015460 | CISPLATIN + FLUOROURACIL |
| 300003384 | 300002361 | 1.71 | 78.1 | 3 | 2013-06-26 | 2013-06-30 | CISPLATIN + FLUOROURACIL | N | N | 300015466 | CISPLATIN + FLUOROURACIL |
| 300003385 | 300002362 | 1.58 | 38.35 | Palliative (P) | 2015-02-02 | 2015-02-14 | Trial Unspecified | null | N | 300015473 | TRIAL |
| 300003386 | 300002363 | 1.58 | 86.4 | Not known (9) | 2016-07-23 | 2016-09-26 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015476 | CISPLATIN + FLUOROURACIL |
| 300003387 | 300002363 | 1.58 | 97.4 | Neo-adjuvant (N) | 2015-04-22 | 2015-04-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015476 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003388 | 300002363 | null | null | Adjuvant (A) | 2017-10-09 | 2017-10-16 | Capecitabine | 02 | N | 300015476 | CAPECITABINE |
| 300003389 | 300002364 | 1.65 | 71 | Palliative (P) | 2016-11-28 | 2016-12-16 | CARBOPLATIN + PACLITAXEL | 02 | N | 300015483 | CARBOPLATIN + PACLITAXEL |
| 300003390 | 300005925 | 1.63 | 41.8 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300015484 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003391 | 300002365 | 1.77 | 59 | Curative (C) | 2013-12-07 | 2013-12-25 | Cetuximab 7 day (Cycle 1) | N | Y | 300015486 | CETUXIMAB |
| 300003392 | 300002366 | 1.73 | 83.55 | Neo-adjuvant (N) | 2012-11-30 | 2013-03-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015490 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003393 | 300002367 | 1.56 | 89 | Palliative (P) | 2016-07-21 | 2016-08-21 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300015492 | CARBOPLATIN + PACLITAXEL |
| 300003394 | 300002367 | 1.58 | 81.7 | Palliative (P) | 2017-10-18 | 2017-10-25 | Trial Unspecified | N | N | 300015492 | TRIAL |
| 300003395 | 300002368 | 1.67 | 57.2 | Neo-adjuvant (N) | 2016-09-12 | 2016-09-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015500 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003396 | 300002369 | 1.7 | 38.35 | Neo-adjuvant (N) | 2014-03-25 | 2014-04-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 300015501 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003397 | 300002370 | 1.77 | 54.5 | Neo-adjuvant (N) | 2014-01-19 | 2014-01-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300015502 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003398 | 300002371 | 1.79 | 97.4 | Curative (C) | 2017-03-01 | 2017-03-01 | Cetuximab + Radiotherapy Maint | Y | Y | 300015503 | CETUXIMAB + RT |
| 300003399 | 300005927 | 1.78 | 60 | Adjuvant (A) | 2015-09-27 | 2015-09-28 | Capecitabine | 02 | null | 300015507 | CAPECITABINE |
| 300003400 | 300002372 | 1.84 | 44 | Adjuvant (A) | 2013-06-12 | 2013-06-15 | Capecitabine | 02 | N | 300015508 | CAPECITABINE |
| 300003401 | 300002373 | 1.66 | 75.9 | Adjuvant (A) | 2016-08-29 | 2016-09-05 | Capecitabine | 2 | N | 300015511 | CAPECITABINE |
| 300003402 | 300002373 | null | null | Neo-adjuvant (N) | 2013-07-03 | 2013-07-04 | CISPLATIN + FLUOROURACIL | null | N | 300015511 | CISPLATIN + FLUOROURACIL |
| 300003403 | 300002373 | null | 57.7 | null | 2017-04-13 | 2017-04-23 | CISPLATIN + FLUOROURACIL | N | N | 300015511 | CISPLATIN + FLUOROURACIL |
| 300003404 | 300002374 | 1.71 | 78.1 | Curative (C) | 2014-10-26 | 2014-10-29 | CETUXIMAB | Y | N | 300015517 | CETUXIMAB |
| 300003405 | 300002375 | 1.5 | null | Adjuvant (A) | 2017-10-05 | 2017-10-06 | Capecitabine | N | N | 300015521 | CAPECITABINE |
| 300003406 | 300002376 | 1.8 | 79.9 | Curative (C) | 2014-11-19 | 2014-11-30 | Cetuximab + Radiotherapy Load | 2 | Y | 300015522 | CETUXIMAB + RT |
| 300003407 | 300002377 | 1.5 | 90 | Palliative (P) | 2013-12-07 | 2013-12-28 | CARBOPLATIN + PACLITAXEL | 02 | N | 300015523 | CARBOPLATIN + PACLITAXEL |
| 300003408 | 300002378 | 1.6 | null | Neo-adjuvant (N) | 2014-05-20 | 2014-06-04 | CISPLATIN + FLUOROURACIL | N | N | 300015526 | CISPLATIN + FLUOROURACIL |
| 300003409 | 300002379 | 1.77 | 106 | Neo-adjuvant (N) | 2016-07-12 | 2016-07-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300015527 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003410 | 300002380 | 1.63 | 104.6 | Palliative (P) | 2013-06-10 | 2014-11-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015528 | CISPLATIN + FLUOROURACIL |
| 300003411 | 300002380 | null | 68.1 | Neo-adjuvant (N) | 2015-02-04 | 2015-02-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015528 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003413 | 300002382 | null | 75.2 | Curative (C) | null | 2014-07-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300015542 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003414 | 300002382 | 1.77 | 65.4 | null | 2016-04-17 | 2016-04-23 | CETUXIMAB + RT | Y | Y | 300015542 | CETUXIMAB + RT |
| 300003415 | 300002382 | 1.66 | 75.2 | null | null | 2014-01-26 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300015542 | CISPLATIN + DOCETAXEL + FLUOROURACIL |